Seeking Alpha

Seeking Alpha Portfolio App for iPad

515 people get SIAL articles and Market Currents by email alert.

Get email alerts on SIAL »

SIAL

Sigma-Aldrich Corporation

5/22/2013, 7:49 AM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, May 8, 10:17 AM Sigma-Aldrich (SIAL) has issued a correction for change in record date and payable date. The revised record date is May 31, payable on June 14. (PR)
Comment! [Dividends]
Wednesday, May 8, 9:06 AM Sigma-Aldrich (SIAL) declares $0.215/share quarterly dividend, in line with previous. Forward yield 1.09%. For shareholders of record June 01. Payable June 15. Ex-div date May 28. (PR) Comment! [Dividends]
Thursday, April 25, 8:33 AM Sigma-Aldrich (SIAL): Q1 EPS of $1.03 beats by $0.02. Revenue of $675M (+2% Y/Y) beats by $2.18M. (PR) Comment! [Earnings, Breaking News]
Monday, April 15, 3:07 AM Thermo Fisher Scientific (TMO) is reportedly closing in on a deal to acquire genetic testing equipment maker Life Technologies (LIFE) for $12.8B after the latter's board chose Thermo Fisher's offer over lower proposals from Sigma-Aldrich (SIAL), a provider of chemicals for research laboratories, and from a consortium involving private-equity firms Blackstone (BX), Carlyle Group (CG) and KKR (KKR). Thermo Fisher has offered $75 a share, 11% above Life's close of $68 on Friday. 1 Comment [Healthcare, M&A, Top Stories]
Thursday, April 11, 10:03 AM Goldman upgrades the Life Sciences Tools & Diagnostics sector to Attractive, but some individual names suffered as Mettler Toledo (MTD -2%) and Sigma-Aldrich (SIAL -1.1%) catch downgrades to Neutral from Buy. SIAL has "few levers to drive EBIT [as] long-term organic growth guidance of 4-6% is too high." Quest Diagnostics (DGX +3.5%) and LabCorp (LH +2%) are upgraded to Buy and Neutral respectively on the former's "untapped capital allocation potential and margin expansion" and the latter's ability to manage pricing pressure. Comment! [On the Move]
Friday, March 15, 7:34 PM If history is a guide, the markets may be due for a pullback, according to S&P Capital's Sam Stovall. Since World War II, Stovall says the median advance once the S&P hits its previous high after recovering from a bear market has been just 3%. But despite the ominous warning, there still may be some places to ride it all out. JPMorgan's chief U.S. equities strategist Tom Lee recently came up with 15 stocks that outperformed the S&P 500 in eight of the last 11 pullbacks since 2009: CAG, IBM, DIS, GPC, MMM, FISV, PAYX, PPG, SYY, SIAL, UNP, UTX, PX, L, and XRAY. 42 Comments [U.S. Economy]
Friday, March 15, 11:19 AM J.P. Morgan's Thomas Lee sees two distinctive style attributes that will help stocks outperform after the recent run-up: high free cash flow yields and - surprisingly - low dividend yields. Lee's screen produces 15 stocks investors can buy now: CAG, IBM, GPC, MMM, PAYX, UTX, SYY, PPG, PX, UNP, FISV, SIAL, XRAY, L, DIS. 6 Comments [Quick Ideas]
Wednesday, February 13, 5:37 PM Sigma-Aldrich Corporation (SIAL) declares $0.215/share quarterly dividend, 7.5% increase from prior dividend of $0.20. Forward yield 1.12%. For shareholders of record Mar. 01. Payable Mar. 15. Ex-div date Feb. 27. (PR) Comment! [Dividends]
Thursday, February 7, 7:51 AM Sigma-Aldrich (SIAL): Q4 EPS of $0.96 beats by $0.01. Revenue of $655M (+7% Y/Y) misses by $4.55M. (PR) Comment! [Earnings, Breaking News]
Thursday, February 7, 12:05 AM Notable earnings before Thursday’s open: AAP, ALU, BG, CCE, CI, CS, CTSH, EXC, FLIR, FLO, GPK, HLSS, HOT, INGR, KKR, MFC, MPW, MWW, NBL, NNN, NYT, ONNN, OZM, PM, PMT, PTEN, S, SBH, SIAL, SNE, SNI, SPH, SQNS, TDC, TEVA, XYL Comment! [Earnings]
Wednesday, February 6, 5:30 PM Notable earnings before Thursday’s open: AAP, ALU, BG, CCE, CI, CS, CTSH, EXC, FLIR, FLO, GPK, HLSS, HOT, INGR, KKR, MFC, MPW, MWW, NBL, NNN, NYT, ONNN, OZM, PM, PMT, PTEN, S, SBH, SIAL, SNE, SNI, SPH, SQNS, TDC, TEVA, XYL 1 Comment [Earnings]
Wednesday, February 6, 5:14 PM More on Sangamo Biosciences (SGMO): Q4 beats on both top and bottom line as higher revenues were generated from the Company's collaboration agreements with Shire (SHPG), Dow AgroSciences (DAS) and Sigma-Aldrich Corporation (SIAL), plus additional research grants. The company guides FY2013 revenue slightly to the lower side of estimates, now expecting to earn between $20M -24M, versus the consensus of $23.09M. Shares -1% AH. Comment! [Healthcare, Earnings, On the Move]
Wednesday, February 6, 10:27 AM Sigma-Aldrich (SIAL -0.7%) slips on a less-than-stellar Neutral initation at Goldman Sachs with an equally less impressive $80 price target. Goldman says the stock is currently trading at a slightly premium to its long-term multiple against both the tools group and the S&P 500, suggesting the market prefers more defensive plays in life sciences. 1 Comment [On the Move]
Friday, November 16, 2012, 11:29 AM Sigma-Aldrich (SIAL) declares $0.20/share quarterly dividend, in line with previous. Forward yield 1.15%. For shareholders of record Nov. 30. Payable Dec. 14. Ex-div Nov. 28. (PR) Comment! [Dividends]
Tuesday, October 23, 2012, 8:08 AM Sigma-Aldrich (SIAL): Q3 EPS of $0.94 in-line. Revenue of $639M (+2% Y/Y) misses by $18M. Shares -4.1% premarket. (PR) Comment! [Earnings, On the Move]
Tuesday, July 24, 2012, 8:20 AM Sigma-Aldrich (SIAL): Q2 EPS of $0.97 in-line. Revenue of $664M (+4.2% Y/Y) misses by $10M. Shares -2.4% premarket. (PR) Comment! [Earnings, On the Move]